Anxiety and methylphenidate in attention deficit hyperactivity disorder: A double-blind placebo-drug trial

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 4, Issue 3, 2012, Pages 153-158

  Moshe, Keren ^a   Karni, Avi ^b   Tirosh, Emanuel ^c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anxiety; Attention deficit hyperactivity disorder; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ANXIETY; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMPULSIVENESS; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEX DIFFERENCE;

ANXIETY; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOUBLE-BLIND METHOD; HUMANS; MALE; METHYLPHENIDATE; SEVERITY OF ILLNESS INDEX;

EID: 84865811134     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-012-0078-2     Document Type: Article

References (40)

1. AACAP Official Action (2007) Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46(7): 894-921.
2. Abikoff H, McGough J, Vitiello B et al (2005) Sequential pharmacotherapy for children with comorbid attention deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44(5): 418-427.
3. Adler AL, Barley RA, Newcorn JH et al (2007) Managing ADHD in children, adolescents, and adults with comorbid anxiety in primary care. J Clin Psychiatry 9(2): 129-138.
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV)). American Psychiatric Association, Washington.
5. Angold S, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiatry 40(1): 57-87.
6. Bedard AC, Tannock R (2008) Anxiety, methylphenidate response and working memory in children with ADHD. J Atten Disord 11(5): 546-547.
7. Biederman J, Newcorn J, Sprich S (1991) Comorbidity of a attention deficit by hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 148(5): 564-577.
8. Biederman J, Hirshleft Becker DR, Rosenbaum JF et al (2001) Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry 158(10): 1673-1679.
9. Brown RT, Amler RW, Freeman WS et al (2005) American Academy of Pediatrics the Committee on Quality Improvement. American Academy of Subcommittee on Attention-Deficit/Hyperactivity disorder. Pediatrics 115(6): e749-e757.
10. Carter S, Syed-Sabir H (2008) How to use a rating score to diagnose attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 93(5): 159-162.
11. Daleiden EL, Vasey MV (1997) An informative-processing perspective on childhood anxiety. Clin Psychol Rev 17(4): 407-429.
12. Diamond IR, Tannock R, Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 38(4): 402-409.
13. DuPaul G, Barkley RA, McMurray MB (1994) Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33(60): 894-903.
14. Efron D, Jarman F, Barker M (1997) Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(6): e6.
15. Eiraldi RB, Power TJ, Nezu CM (1997) Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children. J Am Acad Child Adolesc Psychiatry 36(4): 503-514.
16. Etkin A, Klemenhagen KC, Dudman JT, Rogan MT, Hen R, Kandel ER, Hirsch J (2004) Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces. Neuron 44(6): 1043-1055.
17. Ghanizadeh A (2008) Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender. J Neurol 24(6): 679-684.
18. Goez H, Back-Bennet O, Zelnic N (2007) Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorders. J Child Neurol 22(5): 538-542.
19. Goyette CH, Conners CK, Ulrich RF (1978) Normative data on revised Conners Parent Teachers Rating Scales. J Abnorm Child Psychol 6(2): 221-226.
20. Gray JA (1987) The psychology of fear and stress. Cambridge University Press, New York.
21. Hechtman L, Abikoff H, Klein RG et al (2004) Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43(7): 812-819.
22. Kagan J (1965) The matching familiar figures test. Harvard University Press, Cambridge.
23. Kellogg J, Hopko DR, Ashcraft MH (1999) The effect of time pressure on arithmetic performance. J Anxiety Disord 13(6): 591-600.
24. Lahey BB, Pelham WE, Schaughency EA et al (1988) Dimensions and types of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 27(3): 330-335.
25. Levine MD (1992) The ANSER system. Pediatrics 89(1): 170-171.
26. Livingstone RL, Dykman J, Ackerman PT (1992) Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychol 2(2): 115-122.
27. March JS, Swanson JM, Arnold LE, Hoza B et al (2000) Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol 28(6): 527-541.
28. Milberger S, Biederman J, Faraone SV et al (1995) Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry 152(12): 1793-1799.
29. Or D, Cohen A, Tirosh E (2010) The reliability and validity of the aggregate neurobehavioral student health and educational review parent's questionnaire (ANSER-PQ). J Child Neurol 25(2): 157-164.
30. Pliszka S (1989) Effect of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Psychiatry 28(6): 882-887.
31. Pliszka SR (1992) Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. J Am Acad Child Psychiatry 31(2): 197-203.
32. Pliszka S (1998) Comorbidity of attention-deficit hyperactivity disorder with psychiatric disorder. An overview. J Clin Psychiatry 59(7): 50-58.
33. Power TJ, Costigan TE, Eiraldi RB et al (2004) Variations in anxiety and depression as a function of ADHD subtypes defined by DSM-IV: do subtype differences exist or not. J Abnorm Child Psychol 32(1): 27-37.
34. Schmidt SL, Snyder TJ, Rouget AC et al (2000) Empirical analysis of the selective attention and associated behavior checklists of the aggregate neurobehavioral student health and educational review. J Dev Behav Pediatr 21(3): 165-171.
35. Spencer TJ (2006) ADHD and comorbidity in childhood. J Clin Psychiatry 67(8): 27-31.
36. Spencer T, Biederman J, Wilens T (1999) Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin N Am 46(5): 915-927.
37. Tannock R, Ichowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34(7): 886-896.
38. Tirosh E, Elhasid R, Cohen-Bar Kamah S et al (1993) Predictive value of placebo methylphenidate. Pediatr Neurol 9(2): 131-133.
39. Vila G, Nollet-Clemencon C, de Blic J et al (1999) Assessment of anxiety disorders in asthmatic children. Psychosomatics 40(5): 404-413.
40. Volk HE, Neuman RJ, Todd RD (2005) A systematic evaluation of ADHD and comorbid psychopathology in a population-based twin sample. J Am Acad Child Adolesc Psychiatry 44(8): 768-775.